The inward rectifier current inhibitor PA‐6 terminates atrial fibrillation and does not cause ventricular arrhythmias in goat and dog models
Open Access
- 24 May 2017
- journal article
- research article
- Published by Wiley in British Journal of Pharmacology
- Vol. 174 (15) , 2576-2590
Abstract
Background and Purpose: The density of the inward rectifier current (IK1) increases in atrial fibrillation (AF), shortening effective refractory period and thus promoting atrial re‐entry. The synthetic compound pentamidine analogue 6 (PA‐6) is a selective and potent IK1inhibitor. We tested PA‐6 for anti‐AF efficacy and potential proarrhythmia, using established models in large animals.Experimental Approach: PA‐6 was applied i.v. in anaesthetized goats with rapid pacing‐induced AF and anaesthetized dogs with chronic atrio‐ventricular (AV) block. Electrophysiological and pharmacological parameters were determined.Key Results: PA‐6 (2.5 mg·kg−1·10 min−1) induced cardioversion to sinus rhythm (SR) in 5/6 goats and prolonged AF cycle length. AF complexity decreased significantly before cardioversion. PA‐6 accumulated in cardiac tissue with ratios between skeletal muscle : atrial muscle : ventricular muscle of approximately 1:8:21. In SR dogs, PA‐6 peak plasma levels 10 min post infusion were 5.5 ± 0.9 μM, PA‐6 did not induce significant prolongation of QTc and did not affect heart rate, PQ or QRS duration. In dogs with chronic AV block, PA‐6 did not affect QRS but lengthened QTc during the experiment, but not chronically. PA‐6 did not induce TdP arrhythmias in nine animals (0/9) in contrast to dofetilide (5/9). PA‐6 (200 nM) inhibited IK1, but not IK,ACh, in human isolated atrial cardiomyocytes.Conclusion and Implications: PA‐6 restored SR in goats with persistent AF and, in dogs with chronic AV block, prolonged QT intervals, without inducing TdP arrhythmias. Our results demonstrate cardiac safety and good anti‐AF properties for PA‐6.Keywords
Funding Information
- Deutsche Forschungsgemeinschaft (DFG Do 769/4‐1, DFG VO 1568/3‐1, IRTG1816 RP12)
- Deutsche Forschungsgemeinschaft (IRTG1816 RP12, DFG VO 1568/3‐1)
- Deutsches Zentrum für Herz-Kreislaufforschung
- Deutsche Forschungsgemeinschaft (Do 769/4‐1)
- National Institutes of Health (R01‐HL131517)
This publication has 73 references indexed in Scilit:
- Chloroquine Terminates Stretch-Induced Atrial Fibrillation More Effectively Than Flecainide in the Sheep HeartCirculation: Arrhythmia and Electrophysiology, 2012
- Comparison of the IKrblockers moxifloxacin, dofetilide and E‐4031 in five screening models of pro‐arrhythmia reveals lack of specificity of isolated cardiomyocytesBritish Journal of Pharmacology, 2011
- Structural bases for the different anti-fibrillatory effects of chloroquine and quinidineCardiovascular Research, 2011
- Time course and mechanisms of endo-epicardial electrical dissociation during atrial fibrillation in the goatCardiovascular Research, 2010
- Animal research: Reporting in vivo experiments: The ARRIVE guidelinesBritish Journal of Pharmacology, 2010
- Small-Molecule Modulators of Inward Rectifier K+Channels: Recent Advances and Future PossibilitiesFuture Medicinal Chemistry, 2010
- The anti‐protozoal drug pentamidine blocks KIR2.x‐mediated inward rectifier current by entering the cytoplasmic pore region of the channelBritish Journal of Pharmacology, 2010
- Up‐regulation of the inward rectifier K+ current (IK1) in the mouse heart accelerates and stabilizes rotorsThe Journal of Physiology, 2006
- Atrial fibrillation as an independent risk factor for stroke: the Framingham Study.Stroke, 1991
- Effects of potassium conductance inhibitors on spontaneous diastolic depolarization and abnormal automaticity in human atrial fibersBasic Research in Cardiology, 1986